a public good project by the
Synthesis
Company
of California

© 2026

Jean-François Lévesque | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Jean-François Lévesque

Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Merck Canada Inc. (Canada)(CA)

Research Areas

Drug Transport and Resistance Mechanisms, Inflammatory mediators and NSAID effects, Neuropeptides and Animal Physiology

Most-Cited Works

→ Discovery of a Potent and Selective Prostaglandin D₂ Receptor Antagonist, [(3R)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic Acid (MK-0524)(2007)170 cited